Table of Contents
International Journal of Molecular Imaging
Volume 2011 (2011), Article ID 679473, 8 pages
http://dx.doi.org/10.1155/2011/679473
Clinical Study

Demonstrating Intertumoural Differences in Vascular-Metabolic Phenotype with Dynamic Contrast-Enhanced CT-PET

1Brighton and Sussex Medical School, University of Sussex, Brighton BN1 9RH, UK
2Clinical Imaging Sciences Centre, Brighton and Sussex Medical School, University of Sussex, Falmer, Brighton BN1 2PB, UK
3Queensland PET Service, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia

Received 20 January 2011; Accepted 24 February 2011

Academic Editor: Franklin C. L. Wong

Copyright © 2011 K. A. Miles et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Miles and R. E. Williams, “Warburg revisited: imaging tumour blood flow and metabolism,” Cancer Imaging, vol. 8, no. 1, pp. 81–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Ahuja, R. E. Coleman, J. Herndon, and E. F. Patz, “The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma,” Cancer, vol. 83, no. 5, pp. 918–924, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. J. F. Vansteenkiste, S. G. Stroobants, P. J. Dupont et al., “Prognostic importance of the standardized uptake value on 18F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases,” Journal of Clinical Oncology, vol. 17, no. 10, pp. 3201–3206, 1999. View at Google Scholar
  4. K. Higashi, Y. Ueda, Y. Arisaka, T. Skuma, Y. Nambu, and M. Oguchi, “18-F-FDG uptake as a biological prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer,” The Journal of Nuclear Medicine, vol. 43, pp. 39–45, 2002. View at Google Scholar
  5. H. J. Jeong, J. J. Min, J. M. Park et al., “Determination of the prognostic value of [18-F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer,” Nuclear Medicine Communications, vol. 23, no. 9, pp. 865–870, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. J. Downey, T. Akhurst, M. Gonen et al., “Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection,” Journal of Clinical Oncology, vol. 22, no. 16, pp. 57–63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Fontanini, D. Bigini, S. Vignati et al., “Microvessel count predicts metastatic disease and survival in non-small cell lung cancer,” Journal of Pathology, vol. 177, no. 1, pp. 57–63, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. A. P. Meert, M. Paesmans, B. Martin et al., “The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis,” British Journal of Cancer, vol. 87, no. 7, pp. 694–701, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. L. K. Dunnwald, J. R. Gralow, G. K. Ellis et al., “Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer,” Journal of Clinical Oncology, vol. 26, no. 27, pp. 4449–4457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Xie, J. Zhang, P. H. Wu et al., “Bladder transitional cell carcinoma: correlation of contrast enhancement on computed tomography with histological grade and tumour angiogenesis,” Clinical Radiology, vol. 60, no. 2, pp. 215–223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. U. Tateishi, M. Kusumoto, H. Nishihara, K. Nagashima, T. Morikawa, and N. Moriyama, “Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma,” Cancer, vol. 95, no. 4, pp. 835–842, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Hayashi, M. Tozaki, M. Sugisaki, N. Yoshida, K. Fukuda, and H. Tanabe, “Dynamic multislice helical CT of ameloblastoma and odontogenic keratocyst: correlation between contrast enhancement and angiogenesis,” Journal of Computer Assisted Tomography, vol. 26, no. 6, pp. 922–926, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. S. J. Swensen, L. R. Brown, T. V. Colby, A. L. Weaver, and D. E. Midthun, “Lung nodule enhancement at CT: prospective findings,” Radiology, vol. 201, no. 2, pp. 447–455, 1996. View at Google Scholar · View at Scopus
  14. M. Jinzaki, A. Tanimoto, M. Mukai et al., “Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis,” Journal of Computer Assisted Tomography, vol. 24, no. 6, pp. 835–842, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. C. A. Yi, K. S. Lee, E. A. Kim et al., “Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density,” Radiology, vol. 233, no. 1, pp. 191–199, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. P. Li, Q. F. Meng, C. H. Sun et al., “Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation,” World Journal of Gastroenterology, vol. 11, no. 9, pp. 1287–1291, 2005. View at Google Scholar · View at Scopus
  17. M. A. Haider, M. Milosevic, A. Fyles et al., “Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements,” International Journal of Radiation Oncology Biology Physics, vol. 62, no. 4, pp. 1100–1107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. E. Pollard, T. C. Garcia, S. M. Stieger, K. W. Ferrara, A. R. Sadlowski, and E. R. Wisner, “Quantitative evaluation of perfusion and permeability of peripheral tumors using contrast-enhanced computed tomography,” Investigative Radiology, vol. 39, no. 6, pp. 340–349, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Cenic, D. G. Nabavi, R. A. Craen, A. W. Gelb, and T. Y. Lee, “A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps,” American Journal of Neuroradiology, vol. 21, no. 3, pp. 462–470, 2000. View at Google Scholar · View at Scopus
  20. T. G. Purdie, E. Henderson, and T. Y. Lee, “Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour,” Physics in Medicine and Biology, vol. 46, no. 12, pp. 3161–3175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Hattori, T. Miyoshi, J. Okada, K. Yoshikawa, N. Arimizu, and N. Hattori, “Tumor blood flow measured using dynamic computed tomography,” Investigative Radiology, vol. 29, no. 10, pp. 873–876, 1994. View at Publisher · View at Google Scholar · View at Scopus
  22. K. A. Miles, M. R. Griffiths, and C. J. Keith, “Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 33, no. 1, pp. 22–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Hirasawa, Y. Tsushima, H. Takei et al., “Inverse correlation between tumor perfusion and glucose uptake in human head and neck tumors,” Academic Radiology, vol. 14, no. 3, pp. 312–318, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Bisdas, K. Spicer, and Z. Rumboldt, “Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging,” American Journal of Neuroradiology, vol. 29, no. 7, pp. 1376–1381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Groves, G. C. Wishart, M. Shastry et al., “Metabolic-flow relationships in primary breast cancer: feasibility of combined PET/dynamic contrast-enhanced CT,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 3, pp. 416–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Stewart, K. Talks, R. Leek et al., “Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma,” Histopathology, vol. 40, no. 3, pp. 253–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. F. H. Passam, M. G. Alexandrakis, M. Kafousi et al., “Histological expression of angiogenic factors: VEGF, PDGFRα, and HIF-1α in Hodgkin lymphoma,” Pathology Research and Practice, vol. 205, no. 1, pp. 11–20, 2009. View at Publisher · View at Google Scholar
  28. H. W. M. Van Laarhoven, J. H. A. M. Kaanders, J. Lok, W. J. M. Peeters, P. F. J. W. Rijken, and B. Wiering, “Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer,” International Journal of Radiation Oncology Biology Physics, vol. 64, no. 2, pp. 473–482, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Naumann, A. Vaic, B. Beuthien-Baumann, J. Bredow, J. Kropp, and T. Kittner, “Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma,” British Journal of Haematology, vol. 115, no. 4, pp. 793–800, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. K. A. Miles, D. A. C. Leggett, B. B. Kelley, M. P. Hayball, R. Sinnatamby, and I. Bunce, “In vivo assessment of neovascularization of liver métastases using perfusion CT,” British Journal of Radiology, vol. 71, pp. 276–281, 1998. View at Google Scholar · View at Scopus
  31. K. A. Miles, “Measurement of tissue perfusion by dynamic computed tomography,” British Journal of Radiology, vol. 64, no. 761, pp. 409–412, 1991. View at Google Scholar · View at Scopus
  32. G. L. Semenza, “HIF-1 and tumor progression: pathophysiology and therapeutics,” Trends in Molecular Medicine, vol. 8, no. 4, supplement, pp. S62–S67, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Dimitrakopoulou-Strauss, L. G. Strauss, H. Goldschmidt, W. J. Lorenz, W. Maier-Borst, and G. Van Kaick, “Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas,” European Journal of Nuclear Medicine, vol. 22, no. 5, pp. 434–442, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. K. I. Fukuda, H. Taniguchi, T. Koh, S. Kunishima, and H. Yamagishi, “Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using O and F- deoxyglucose,” Nuclear Medicine Communications, vol. 25, no. 6, pp. 577–583, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. P. E. Dugdale, K. A. Miles, I. Bunce, B. B. Kelley, and D. A. C. Leggett, “CT measurement of perfusion and permeability within lymphoma masses and its ability to assess grade, activity, and chemotherapeutic response,” Journal of Computer Assisted Tomography, vol. 23, no. 4, pp. 540–547, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Veronesi, C. Landoni, G. Pelosi et al., “Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases,” British Journal of Cancer, vol. 86, no. 9, pp. 1391–1395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. D. A. Mankoff, L. K. Dunnwald, J. R. Gralow, G. K. Ellis, A. Charlop, and T. J. Lawton, “Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy,” Journal of Nuclear Medicine, vol. 43, no. 4, pp. 500–509, 2002. View at Google Scholar · View at Scopus
  38. U. Tateishi, H. Nishihara, E. Tsukamoto, T. Morikawa, N. Tamaki, and K. Miyasaka, “Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism,” Journal of Computer Assisted Tomography, vol. 26, no. 2, pp. 185–190, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. Hoekstra, S. G. Stroobants, O. S. Hoekstra, E. F. Smit, J. F. Vansteenkiste, and A. A. Lammertsma, “Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography,” Clinical Cancer Research, vol. 8, no. 7, pp. 2109–2115, 2002. View at Google Scholar · View at Scopus
  40. G. Komar, S. Kauhanen, and K. Liukko, “Imaging perfusion and metabolism of malignant and benign pancreatic lesions using positron emission tomography,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, supplement 2, p. S147, 2008. View at Google Scholar
  41. R. S. Herbst, N. A. Mullani, D. W. Davis et al., “Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin,” Journal of Clinical Oncology, vol. 20, no. 18, pp. 3804–3814, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. C. G. Willett, Y. Boucher, E. Di Tomaso et al., “Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer,” Nature Medicine, vol. 10, no. 2, pp. 145–147, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. K. A. Miles, “PET-CT in oncology: making the most of CT,” Cancer Imaging, vol. 8, supplement, pp. S87–S93, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Antoch, L. S. Freudenberg, T. Beyer, A. Bockisch, and J. F. Debatin, “To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT,” Journal of Nuclear Medicine, vol. 45, supplement 1, pp. 56S–65S, 2004. View at Google Scholar · View at Scopus
  45. A. Dimitrakopoulou-Strauss, L. G. Strauss, C. Burger et al., “Prognostic aspects of F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy,” Journal of Nuclear Medicine, vol. 45, no. 9, pp. 1480–1487, 2004. View at Google Scholar · View at Scopus